Navigation Links
Cord Blood America CEO Matthew Schissler Interviewed by BIONOVA, Greece's Leading Biotech Magazine
Date:2/12/2008

SANTA MONICA, Calif., Feb. 12 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced that CEO Matthew L. Schissler was interviewed by the leading biotechnology publication in Greece, where Cord Blood America established a partnership in 2006 named a.bourkas Co., United.

"Stem cells are used today in the treatment of leukemia, breast cancer, lymphoma, Hodgkin's Disease, aplastic anemia, sickle cell anemia, various other cancers, blood diseases, hereditary and genetic conditions and immune system disorders," Mr. Schissler said in the interview. "As stem cell transplants become routine, they may be used to fight many other cancers, viruses and genetic disorders."

"Umbilical cord stem cells are used to repopulate one's immune system. An example would be a leukemia patient who undergoes radiation therapy. The stem cells from the umbilical cord repopulate the patient's immune system with healthy cells to keep the body strong and to help fight other diseases," Cord Blood America's CEO said.

Mr. Schissler further explained that, "umbilical cord stem cells are a perfect match for the baby, but because of close genetic ties, there is a good chance they will match for immediate family members as well. They also may be a very good match for a sibling. Umbilical cord stem cells are the best because they have hematapoletic traits, meaning they repopulate the immune system and have regenerative traits meaning they can regenerate tissue."

Andreas Bourkas, Director and Manager of a.bourkas Co., United, said saving the umbilical cord at birth is starting to be a popular choice. "Greek's have very strong family ties and this is exactly the right step for a fam
'/>"/>

SOURCE Cord Blood America, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. CORD:USE Cord Blood Bank Announces the Addition of Dr. John Wagner, a Pioneer in the Use of Umbilical Cord Blood Stem Cells, to Its Scientific Advisory Board
2. National Association of Emergency Medical Technicians (NAEMT) Supports Prehospital Screening for Carbon Monoxide in the Blood
3. Dr. Charles A. Sims of California Cryobanks Family Cord Blood Services Named to National Stem Cell Advisory Council
4. Video and Photo: Tekturna HCT(R), a Single-tablet Combination of Tekturna(R)* and a Diuretic, Receives US Approval for Treatment of High Blood Pressure
5. Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
6. GeneNews initiates patient sample accrual for validation studies of colon cancer blood test
7. A&G Pharmaceutical Receives $870,000 Grant from Avon Foundation to Advance Innovative Blood Diagnostic Test for Early Detection of Breast Cancer
8. 49th Annual Meeting of the American Society of Hematology Will Feature the Latest Research in Blood Diseases
9. FDA Approves Diovan(R) for Treatment of High Blood Pressure in Children
10. Cord Blood America Announces Financing
11. AspenBio Pharma Pursues FDA 510(k) Application Pathway for Appendicitis Blood Test

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...4-year veteran of the high-technology industry, ha...development and intellectual property management c...e. The company also plans to invest in promising .... , Monterey, CA (PRWEB) ...veteran of the high-technology industry, has forme...
(Date:11/30/2009)...wire/ -- Acuo Technologies, developers of high-per...igration tools and services, today announced contr... Vendor Neutral Archive (VNA), providing the found...f hospitals, clinics and affiliates. ,, The arc...DICOM Services Grid(TM) Software. The Acuo VNA ar...
(Date:11/30/2009)...wire/ -- Biopharmaceutical company Kiadis,Pharma a...nrolled in its,multinational registration clinical...w reduction in transplant related mortality (TRM) ...ransplantation with a mismatched,(haplo-identical)...logeneic,stem cell transplantation but without hav...
(Date:11/30/2009)...FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq...dministration (FDA) has granted orphan drug design...dine phosphate, for the rare autoimmune disease La...as previously received orphan drug designation in ... Medicinal Products for Human Use of the European ...
Breaking Biology Technology:Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4
...ell Sciences", "SCS", "the Company"), Stem Cell S... on the,commercialisation of stem cells and stem c...to an agreement with CHDI Foundation, Inc., to sup...ryonic stem (ES) cell lines. CHDI,is a US non-prof...,s,disease (HD). The cell lines have been produced...
.... today announced that it is expanding its biomanu...o Thermo Scientific HyClone Single-Use,Bioreactors.... These,innovative systems will further enhance Av...ll culture production services. The purchase of th...of the 100 L S.U.B. in Avid,s,process development ...
...y announced that the Max Planck Institute of Bioch...x, MATLAB Distributed Computing Server, and other ...stically reduce research and development time. ,...ire EON) November 10, 2008 -- Researchers at the ...Max Planck Institute of Biochemistry, based in Mar...
Other Biology Technology:Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 2Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 3Stem Cell Sciences Enters into Services Agreement with Huntingdon's Disease Research Group, CHDI Foundation Inc. 4Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems 2Avid Bioservices Expands Capabilities With Installation of Innovative Thermo Scientific HyClone Single-Use Bioreactor Systems 3 Max Planck Institute of Biochemistry Uses MathWorks Tools in Its Quest to Cure Cancer : Institute Accelerates Reconstruction of Key Protein Complexes Using MATLAB and Parallel Computing Toolbox 2 Max Planck Institute of Biochemistry Uses MathWorks Tools in Its Quest to Cure Cancer : Institute Accelerates Reconstruction of Key Protein Complexes Using MATLAB and Parallel Computing Toolbox 3
(Date:12/1/2009)... Ohio State University cancer researchers have de...rain-tumor cells and blocks the growth of new tumo...uses designed to kill cancer cells oncolytic viru...ain tumors if they also carry a gene for a protein..., called vasculostatin, is normally produced in th...
(Date:12/1/2009)...ientists, one from the United States, the other fr... leader of his wolf pack, on remote Ellesmere Isla... to finally find out what these "North Pole wolve...he harshest areas of the world., "We first encou... Mech, a renowned U.S. Geological Survey (USGS) wo...
(Date:12/1/2009)...st, a Monash University-led international research... output of the next generation of solar cells. , ... with colleagues from the universities of Wollongo...nsitised solar cells with a three-fold increase in...usly reported tandem dye-sensitised solar cells. ...
Breaking Biology News(10 mins):Tumor-attacking virus strikes with 'one-two punch' 2North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3Innovation puts next-generation solar cells on the horizon 2Heavy Periods May Be Due to a Clotting Disorder 48094 1Heavy Periods May Be Due to a Clotting Disorder 48094 2New Debt Securities of US Oncology Inc 48091 1New Debt Securities of US Oncology Inc 48091 2New Debt Securities of US Oncology Inc 48091 3NxStage Announces Closing of 2440 Million Debt Financing with Asahi Kasei Kuraray Medical 48089 1NxStage Announces Closing of 2440 Million Debt Financing with Asahi Kasei Kuraray Medical 48089 2
...easuring blood levels of specialized cells that ci...e arterial lining has been discovered by Duke Univ...known as endothelial progenitor cells (EPC), are p...of arterial damage. , The researchers said that te...egree of coronary artery disease or risks for suff...
...y of Saskatchewan,s Vaccine and Infectious Disease...idate for hepatitis C, leading to hope in the figh...available. , VIDO is the first in Canada to show t...ainst HCV. The study was published in this month,s... by the Canadian Institutes of Health Research (CI...
...y of Pennsylvania School of Medicine have develope...mounts of proteins in the blood. Applications of t...cules associated with cancers (such as breast canc...ibly psychiatric diseases relatively easy and more...ncluding the widely used ELISA (enzyme-linked immu...
Other Biology News:Measuring artery repair cells could become new heart disease test 2Measuring artery repair cells could become new heart disease test 3U of S researchers develop new vaccine candidate against hepatitis C 2New test to detect rare proteins in blood 2New test to detect rare proteins in blood 3New test to detect rare proteins in blood 4New test to detect rare proteins in blood 5
Rabbit Anti-3-Ethynylestradiol Polyclonal Antibody, Unconjugated from Abcam
Anti-Ku (p70 / p80) Ab-3 Monoclonal Antibody, Unconjugated from Lab Vision
SV40 Large T Antigen from Chimerx
Rabbit Anti-Rat 5-HIAA Polyclonal Antibody, Unconjugated from ImmunoStar, Inc.
Biology Products: